Inventor · disambiguated record
Shadmehr Demehri
Also filed as: DEMEHRI SHADMEHR
3 granted patents·7 pending applications·2 citations·filing 2015–2024
56Inventor score
Top patents by PatentIndex Score
10 records- 0178US10905763B2Compositions and methods for treatment of pre-cancerous skin lesionsUNIV WASHINGTON·Filed 2015·Granted Feb 2, 2021·2 cites·5 claims
- 0272US12186394B2Compositions and methods for treatment of pre-cancerous skin lesionsWASHINGTON UNIVERSITY ST LOUIS·Filed 2022·Granted Jan 7, 2025·0 cites·19 claims
- 0369US2025221982A1Compositions and methods for local delivery of pharmaceutical agents to treat cancerMASSACHUSETTS GEN HOSPITAL·Filed 2024·Application pending·0 cites
- 0465US11478549B2Compositions and methods for treatment of pre-cancerous skin lesionsUNIV WASHINGTON·Filed 2021·Granted Oct 25, 2022·0 cites·8 claims
- 0553US2025288671A1Ecm receptor modulation in nk cell therapyMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 0652US2024287194A1Targeting Extracellular Matrix Proteins to Regulate NK Cell Function in Peripheral TissuesMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 0752US2023255954A1Interleukin 33 (il-33) inhibition for treatment of cancer, fibrosis and inflammationMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 0852US2021177831A1Compositions and methods for local delivery of pharmaceutical agents to treat cancerMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
- 0951US2024100141A1T cell-directed anti-cancer vaccines against commensal viruses for treating mucosal carcinomasMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 1046US2022001004A1T Cell-Directed Anti-Cancer Vaccines Against Commensal VirusesMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shadmehr Demehri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →